Aurdan Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.79M Buy
11,353
+73
+0.6% +$29.1K 1.05% 26
2026
Q2
$4.08M Sell
11,280
-219
-2% -$75K 1.04% 25
2026
Q1
$4.05M Sell
11,499
-18
-0.2% -$6.42K 1.21% 21
2025
Q4
$3.77M Sell
11,517
-68
-0.6% -$21.6K 1.16% 20
2025
Q3
$3.27M Sell
11,585
-5,316
-31% -$1.54M 1.04% 24
2025
Q2
$4.72M Sell
16,901
-4,937
-23% -$1.4M 1.61% 16
2025
Q1
$6.8M Sell
21,838
-3,437
-14% -$1.01M 2.56% 11
2024
Q4
$6.59M Buy
+25,275
New +$7.5M 2.53% 12

Other funds holding AMGN

Aurdan Capital Management's AMGN Position: Q3 2026 in Review

Aurdan Capital Management increased its Amgen (AMGN) stake by 0.65% in Q3 2026, buying an estimated $29.1K and bringing the position to 11,353 shares worth $4.79M. The position accounts for 1.05% of the portfolio, ranked #26.

Aurdan Capital Management first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $6.8M in Q1 2025. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Aurdan Capital Management held 11,353 shares of Amgen worth $4.79M as of Q3 2026.
  • Aurdan Capital Management bought 73 Amgen shares in Q3 2026, an estimated $29.1K.
  • Amgen made up 1.05% of Aurdan Capital Management's portfolio in Q3 2026, its #26 holding.
  • Aurdan Capital Management first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • Aurdan Capital Management's Amgen position peaked at $6.8M in Q1 2025.
  • 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Aurdan Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.